Avoidant/restrictive food intake disorder (ARFID) affects an estimated 4.5% to 11% of the general population, depending on how strictly researchers apply diagnostic criteria. Even the lower end of that range makes ARFID one of the more common eating disorders, yet it remains underdiagnosed because many people, and many clinicians, still confuse it with ordinary picky eating.
Prevalence in the General Population
A 2024 meta-analysis pooling 26 studies and over 122,000 participants found an overall ARFID prevalence of about 11%. When the researchers adjusted for study quality and used stricter methods, the estimate dropped to 4.5%. Both figures are higher than most people expect for an eating disorder that was only formally recognized in the DSM-5 in 2013. For comparison, anorexia nervosa affects roughly 1% to 2% of the population.
Among adults specifically, data from a large National Eating Disorders Association screening of over 50,000 people found that 4.7% screened positive for ARFID. Only 2% of those who screened positive were currently in treatment, suggesting the vast majority of adults with ARFID are not getting help.
Who Is Most Likely to Have ARFID
ARFID shows up across all age groups, but the pattern of who develops it shifts with age. In a Canadian study tracking children and adolescents aged 5 to 18, the overall incidence was about 2 per 100,000 patients per year. Among children under 10, boys were actually slightly more likely to be diagnosed than girls, with a male-to-female ratio of roughly 8:7. That flipped during adolescence: by ages 10 to 14, girls outnumbered boys 2:1, and the gap narrowed only slightly among older teens.
Overall, girls had about 1.7 times the odds of meeting criteria for ARFID compared to boys in adolescent community samples. Boys, however, were more likely to restrict food based on sensory characteristics like texture, taste, or smell (about 51% of boys vs. 32% of girls). Girls more commonly presented with eating too little overall.
About 16% of people with ARFID also have autism, based on a prevalence meta-analysis. That rate is far higher than the roughly 2% to 3% autism prevalence in the general population, which helps explain why ARFID is so frequently discussed in neurodivergent communities.
How ARFID Differs From Picky Eating
Selective eating and food neophobia (reluctance to try new foods) are developmentally normal in young children. Most kids grow out of these phases without lasting consequences. ARFID is diagnosed only when food restriction causes measurable harm: significant weight loss, failure to grow as expected, nutritional deficiencies, dependence on supplements or tube feeding, or serious interference with social functioning. A child who eats a narrow range of foods but is growing normally and hitting developmental milestones does not have ARFID.
The other key distinction is body image. ARFID has nothing to do with wanting to be thinner or controlling body shape. The restriction comes from one or more of three drivers: sensory sensitivity to food textures, tastes, or smells; fear of something bad happening after eating, like choking or vomiting; or a genuine lack of interest in food, where hunger signals are weak or absent. Many people have a mix of these. Research shows about 38% of cases involve more than one subtype, with sensory sensitivity being the most common at 60%, followed by low interest in eating at 39%, and fear of aversive consequences at 15%.
What the Three Subtypes Look Like
People with sensory-driven ARFID often stick to a narrow rotation of plain, predictable foods. Think white bread, plain pasta, chicken nuggets. Mixed textures, strong flavors, or unfamiliar appearances can trigger gagging or intense distress. This is the subtype people most often associate with “extreme picky eating,” but the level of restriction goes far beyond preference.
The fear-based subtype typically develops after a traumatic eating experience, like choking on a piece of food, a severe bout of food poisoning, or painful acid reflux. The person begins avoiding foods they associate with the bad experience, and the avoidance can gradually expand to broader categories of food. In children, this can develop quickly and be hard to reverse without support.
The low-interest subtype is perhaps the least understood. These individuals simply don’t experience hunger the way most people do. Eating feels like a chore. They may forget meals entirely or feel full after a few bites. This subtype can be easy to miss because the person may not seem distressed about food. They just don’t eat enough.
Physical and Nutritional Consequences
Because ARFID limits the variety and quantity of food, it frequently leads to deficiencies in iron, vitamin B12, vitamin C, zinc, and folate. These aren’t minor gaps. Iron deficiency causes fatigue and anemia. Vitamin C deficiency impairs wound healing and immune function. Zinc and B12 shortfalls affect everything from cognition to mood to nerve health.
In severe or long-standing cases, the consequences extend well beyond vitamin levels. Chronic malnutrition from ARFID can cause slowed heart rate and low blood pressure, weakened bones and increased fracture risk, delayed puberty and disrupted growth in children, muscle wasting, hair thinning, immune suppression, and hormonal imbalances. The neuropsychological effects are also significant: problems with memory, attention, concentration, and mood are all documented in people with prolonged ARFID-related malnutrition.
Among adults who screened positive for ARFID in the national screening study, 35% reported suicidal ideation. That number underscores that ARFID is not a quirky food preference. It carries serious mental health consequences, partly from the malnutrition itself and partly from the social isolation that comes with being unable to eat in normal settings.
Why ARFID Is Still Underdiagnosed
Despite affecting millions of people, ARFID flies under the radar for several reasons. It was only added to the psychiatric diagnostic manual in 2013, so many healthcare providers trained before then may not be familiar with it. It doesn’t fit the public image of an eating disorder because there’s no drive for thinness and no binge-purge cycle. Adults with ARFID have often spent decades being told they’re just picky eaters, and many have developed elaborate workarounds (eating before social events, ordering the same safe foods at every restaurant) that mask the severity of their restriction.
In the adult screening data, only 47% of people who screened positive for ARFID said they intended to seek treatment for an eating disorder, and just 2% were currently receiving care. That gap between prevalence and treatment is enormous. Part of the problem is awareness: people can’t seek help for a condition they don’t know exists, and clinicians can’t diagnose what they aren’t looking for.